久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Company Profile

Year Established : 2006
Total Assets(USD) : 500,000 to 99,999,999
Total Number of Staff : 100-500
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
  • Contact Person :
  • Fax:

Zhejiang Changming Pharmaceutical Co., Ltd, established in 2006, is the subsidiary of Zhejiang Shengda Group. Changming specializes in research, development, production and marketing of cardiovascular and other therapeutic drug related APls and intermediates. Changming is one of leading suppliers of pharmaceutical grade ACE inhibitor APIs and intermediates. The leading products include: Enalapril, Ramipril, Lisinopril, Benfotiamine, Doxofylline,etc.

Certificates/Standards

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service